Literature DB >> 19540070

Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.

Alexander Chi1, Mingcheng Gao, James Sinacore, Nam P Nguyen, Faisal Vali, Kevin Albuquerque.   

Abstract

PURPOSE: To compare the dose distribution between customized planning (CP) and adopting a single plan (SP) in multifractionated high-dose-rate brachytherapy and to establish predictors for the necessity of CP in a given patient. METHODS AND MATERIALS: A total of 50 computed tomography-based plans for 10 patients were evaluated. Each patient had received 6 Gy for five fractions. The clinical target volume and organs at risk (i.e., rectum, bladder, sigmoid, and small bowel) were delineated on each computed tomography scan. For the SP approach, the same dwell position and time was used for all fractions. For the CP approach, the dwell position and time were reoptimized for each fraction. Applicator position variation was determined by measuring the distance between the posterior bladder wall and the tandem at the level of the vaginal fornices.
RESULTS: The organs at risk D(2cc) (dose to 2 cc volume) was increased with the SP approach. The dose variation was statistically similar between the tandem and ring and tandem and ovoid groups. The bladder D(2cc) dose was 81.95-105.42 Gy(2) for CP and 82.11-122.49 Gy(2) for SP. In 5 of the 10 patients, the bladder would have been significantly overdosed with the SP approach. The variation of the posterior bladder wall distance from that in the first fraction was correlated with the increase in the bladder D(2cc) (SP/CP), with a correlation coefficient of -0.59.
CONCLUSION: Our results support the use of CP instead of the SP approach to help avoid a significant overdose to the bladder. This is especially true for a decrease in the posterior wall distance of >/=0.5 cm compared with that in the first fraction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540070     DOI: 10.1016/j.ijrobp.2009.03.041

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

Review 1.  American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.

Authors:  Jyoti Mayadev; Akila Viswanathan; Yu Liu; Chin-Shang Li; Kevin Albuquerque; Antonio L Damato; Sushil Beriwal; Beth Erickson
Journal:  Brachytherapy       Date:  2017 Jan - Feb       Impact factor: 2.362

2.  Redesign of process map to increase efficiency: Reducing procedure time in cervical cancer brachytherapy.

Authors:  Antonio L Damato; Larissa J Lee; Mandar S Bhagwat; Ivan Buzurovic; Robert A Cormack; Susan Finucane; Jorgen L Hansen; Desmond A O'Farrell; Alecia Offiong; Una Randall; Scott Friesen; Akila N Viswanathan
Journal:  Brachytherapy       Date:  2015-01-06       Impact factor: 2.362

Review 3.  Image-guided radiotherapy and -brachytherapy for cervical cancer.

Authors:  Suresh Dutta; Nam Phong Nguyen; Jacqueline Vock; Christine Kerr; Juan Godinez; Satya Bose; Siyoung Jang; Alexander Chi; Fabio Almeida; William Woods; Anand Desai; Rick David; Ulf Lennart Karlsson; Gabor Altdorfer
Journal:  Front Oncol       Date:  2015-03-17       Impact factor: 6.244

4.  A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.

Authors:  Rebecca Meerschaert; Adrian Nalichowski; Jay Burmeister; Arun Paul; Steven Miller; Zhenghui Hu; Ling Zhuang
Journal:  J Appl Clin Med Phys       Date:  2016-11-08       Impact factor: 2.102

5.  Evaluation of dosimetric impact of inter-application and intra-application variations in fractionated high-dose-rate intra-cavitary brachytherapy of cervical cancer.

Authors:  Tanvir Pasha; Hanan Naniparuthayil Hassan; Nikhila Radhakrishna; Muhammed Shafeeque N; Ajin Shaji Varghese; Lokesh Viswanath; Nithin Bhaskar Valuvil; Sathiyan S; Govardhan H B; Ibrahim Khaleel; Siddanna Rudrappa Palled; Naveen Thimmaiah
Journal:  J Contemp Brachytherapy       Date:  2021-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.